Terms: = Colorectal cancer AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL AND Treatment
131 results:
1. Pelvic exenteration for locally advanced and recurrent prostate cancer.
Ephraums J; Brown KGM; Solomon MJ; Austin KKS; Lee PJ; Leslie S; Byrne C
Eur J Surg Oncol; 2024 Jul; 50(7):108384. PubMed ID: 38749360
[TBL] [Abstract] [Full Text] [Related]
2. Robotic versus laparoscopic anterior resection for the treatment of stage II and III sigmoid colon cancer: a propensity score-matched analysis.
Wang J; Zhou J; Zhao S; Li R; Fu Y; Sun L; Wang W; Wang L; Wang D
J Robot Surg; 2024 May; 18(1):207. PubMed ID: 38727774
[TBL] [Abstract] [Full Text] [Related]
3. Comparing symptom clusters in cancer survivors by cancer diagnosis: A latent class profile analysis.
Lee LJ; Han CJ; Saligan L; Wallen GR
Support Care Cancer; 2024 Apr; 32(5):308. PubMed ID: 38662054
[TBL] [Abstract] [Full Text] [Related]
4. Discovery of a Meisoindigo-Derived PROTAC as the ATM Degrader: Revolutionizing colorectal cancer Therapy via Synthetic Lethality with ATR Inhibitors.
Liu TT; Wang Q; Zhou Y; Ye B; Liu T; Yan L; Fan J; Xu J; Zhou Y; Xia Z; Deng X
J Med Chem; 2024 May; 67(9):7620-7634. PubMed ID: 38634707
[TBL] [Abstract] [Full Text] [Related]
5. Combining pathological risk factors and T, N staging to optimize the assessment for risk stratification and prognostication in low-risk stage III colon cancer.
Xian ZY; Song YW; Zhang ZJ; Gan YG; Chen YL; Hu T; Wen XF; Mo TW; He XW
World J Surg Oncol; 2024 Jan; 22(1):10. PubMed ID: 38178080
[TBL] [Abstract] [Full Text] [Related]
6. Increase in the Life Expectancy of Patients with cancer in the United States.
Devasia TP; Howlader N; Dewar RA; Stevens JL; Mittu K; Mariotto AB
Cancer Epidemiol Biomarkers Prev; 2024 Feb; 33(2):196-205. PubMed ID: 38015774
[TBL] [Abstract] [Full Text] [Related]
7. The clinicopathological spectrum and treatment outcomes in metastatic colorectal cancer in the KwaZulu-Natal province of South Africa.
Kader S; Moodley Y; Madiba TE
S Afr J Surg; 2023 Jun; 61(2):86-90. PubMed ID: 37381805
[TBL] [Abstract] [Full Text] [Related]
8. WDR54 exerts oncogenic roles in T-cell acute lymphoblastic leukemia.
Li H; Zhang D; Fu Q; Wang S; Zhang X; Lin Z; Wang Z; Song J; Su Z; Xue V; Liu S; Chen Y; Zhou L; Zhao N; Lu D
Cancer Sci; 2023 Aug; 114(8):3318-3329. PubMed ID: 37302808
[TBL] [Abstract] [Full Text] [Related]
9. Bruton's Tyrosine Kinase Inhibitors (BTKIs): Review of Preclinical Studies and Evaluation of Clinical Trials.
Rozkiewicz D; Hermanowicz JM; Kwiatkowska I; Krupa A; Pawlak D
Molecules; 2023 Mar; 28(5):. PubMed ID: 36903645
[TBL] [Abstract] [Full Text] [Related]
10. Progress Against cancer in Kuwait: Trends in Incidence, Survival and Mortality.
E A; A AA; A E; P CM; C A
Gulf J Oncolog; 2023 Jan; 1(41):23-31. PubMed ID: 36804156
[TBL] [Abstract] [Full Text] [Related]
11. Studies on 1,4-Quinone Derivatives Exhibiting Anti-Leukemic Activity along with Anti-colorectal and Anti-Breast cancer Effects.
Ciftci H; Sever B; Kaya N; Bayrak N; Yıldız M; Yıldırım H; Tateishi H; Otsuka M; Fujita M; TuYuN AF
Molecules; 2022 Dec; 28(1):. PubMed ID: 36615273
[TBL] [Abstract] [Full Text] [Related]
12. Adverse events of endoscopic full-thickness resection: results from the German and Dutch nationwide colorectal FTRD registry.
Zwager LW; Mueller J; Stritzke B; Montazeri NSM; Caca K; Dekker E; Fockens P; Schmidt A; Bastiaansen BAJ;
Gastrointest Endosc; 2023 Apr; 97(4):780-789.e4. PubMed ID: 36410447
[TBL] [Abstract] [Full Text] [Related]
13. cancer incidence and mortality in Australia from 2020 to 2044 and an exploratory analysis of the potential effect of treatment delays during the COVID-19 pandemic: a statistical modelling study.
Luo Q; O'Connell DL; Yu XQ; Kahn C; Caruana M; Pesola F; Sasieni P; Grogan PB; Aranda S; Cabasag CJ; Soerjomataram I; Steinberg J; Canfell K
Lancet Public Health; 2022 Jun; 7(6):e537-e548. PubMed ID: 35660215
[TBL] [Abstract] [Full Text] [Related]
14. Rectal MRI radiomics inter- and intra-reader reliability: should we worry about that?
Kwok HC; Charbel C; Danilova S; Miranda J; Gangai N; Petkovska I; Chakraborty J; Horvat N
Abdom Radiol (NY); 2022 Jun; 47(6):2004-2013. PubMed ID: 35366088
[TBL] [Abstract] [Full Text] [Related]
15. Liquid Biopsy-based Precision Therapy in Patients with Advanced Solid Tumors: A Real-world Experience from a Community-based Oncology Practice.
Choucair K; Mattar BI; Van Truong Q; Koeneke T; Van Truong P; Dakhil C; Cannon MW; Page SJ; Deutsch JM; Carlson E; Moore DF; Nabbout NH; Kallail KJ; Dakhil SR; Reddy PS
Oncologist; 2022 Mar; 27(3):183-190. PubMed ID: 35274713
[TBL] [Abstract] [Full Text] [Related]
16. Diversion proctocolitis and the problem of the forgotten rectum in inflammatory bowel diseases: A systematic review.
Dal Buono A; Carvello M; Sachar DB; Spinelli A; Danese S; Roda G
United European Gastroenterol J; 2021 Dec; 9(10):1157-1167. PubMed ID: 34845854
[TBL] [Abstract] [Full Text] [Related]
17. The Mitochondrial Disruptor Devimistat (CPI-613) Synergizes with Genotoxic Anticancer Drugs in colorectal cancer Therapy in a Bim-Dependent Manner.
Arnold C; Demuth P; Seiwert N; Wittmann S; Boengler K; Rasenberger B; Christmann M; Huber M; Brunner T; Linnebacher M; Fahrer J
Mol Cancer Ther; 2022 Jan; 21(1):100-112. PubMed ID: 34750196
[TBL] [Abstract] [Full Text] [Related]
18. Parenchymal-sparing hepatectomy for colorectal liver metastases reduces postoperative morbidity while maintaining equivalent oncologic outcomes compared to non-parenchymal-sparing resection.
Andreou A; Gloor S; Inglin J; Di Pietro Martinelli C; Banz V; Lachenmayer A; Kim-Fuchs C; Candinas D; Beldi G
Surg Oncol; 2021 Sep; 38():101631. PubMed ID: 34298267
[TBL] [Abstract] [Full Text] [Related]
19. Testing strategies for Lynch syndrome in people with endometrial cancer: systematic reviews and economic evaluation.
Stinton C; Jordan M; Fraser H; Auguste P; Court R; Al-Khudairy L; Madan J; Grammatopoulos D; Taylor-Phillips S
Health Technol Assess; 2021 Jun; 25(42):1-216. PubMed ID: 34169821
[TBL] [Abstract] [Full Text] [Related]
20. Adverse events associated with nilotinib in chronic myeloid leukemia: mechanisms and management strategies.
Wang Z; Jiang L; Yan H; Xu Z; Luo P
Expert Rev Clin Pharmacol; 2021 Apr; 14(4):445-456. PubMed ID: 33618586
[No Abstract] [Full Text] [Related]
[Next]
